Event-Driven Stocks

Bio Essence Corp

BIOEOTC

Healthcare · Pharmaceutical Preparations · CA · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 4 good● 1 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$1.9M$323,940$551,506$621,590$887,984$958,700
Operating income$900,011−$459,438−$789,050−$511,138−$857,527−$832,566
Net income$896,197−$1.3M−$971,879−$809,679−$647,564−$595,838
Total assets$422,474$281,024$2.7M$1.5M$1.7M$1.8M
Total liabilities$2.5M$3.3M$4.3M$4.8M$4.1M$3.6M
Equity−$2.1M−$3.0M−$1.7M−$3.2M−$2.4M−$1.8M
EPS (diluted)—$-0.03$-0.02$-0.02$-0.02—
Shares out.38.0M38.0M33.0M33.0M33.0M33.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
47.4%
Net margin
47.2%
Return on equity
−43.2%
Return on assets
212.1%
Return on capital (ROCE)
—
Liabilities / assets
590.7%
Debt / equity
—
Book value / share
$-0.05
Revenue growth (YoY)
485.8%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-91.59distress
Accruals / assets
−159.4%clean
Piotroski F-Score
9/9strong

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
62
/ 100
Profitability 75Growth 100Catalyst 33Earnings quality 100Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 3 severe● 1 warning● 4 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • High leverage (liabilities > 70% of assets)
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20262,5001.0-52.5%
Apr 30, 20265,2621.5-36.3%
Apr 15, 20268,2621.0+22.1%
Mar 31, 20266,7651.0+100.0%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)